NCT00488670终止3 期
An Open-label Study of Escitalopram in the Treatment of Major Depressive Disorder in Elderly Patients With Alzheimer's Disease
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 终止
- 入组人数
- 50
- 试验地点
- 2
- 主要终点
- Change in Cornell Scale for Depression in Dementia (CSDD) from baseline.
研究概览
简要总结
To investigate the effect of Escitalopram in a large and diverse of dementia patients suffering from depression.
详细描述
This study will assess the efficacy, tolerability, and safety of escitalopram in the treatment of Major Depressive Disorder in patients with Alzheimer's disease over a 24-week period. It will also assess the efficacy and tolerability of escitalopram after 12 weeks of treatment.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 50 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •> 50 years
- •Male & female
- •Alzheimer's disease
- •Depressive episode
排除标准
- 未提供
结局指标
主要结局
Change in Cornell Scale for Depression in Dementia (CSDD) from baseline.
次要结局
- Montgomery-Åsberg Depression Rating Scale; Neuropsychiatric Inventory; Alzheimer's Disease Cooperative Study
研究者
研究点 (2)
Loading locations...
相似试验
已完成
3 期
Escitalopram (Lexapro®) In Patients With Major Depression With Atypical FeaturesAtypical DepressionNCT00610506Duke University15
已完成
不适用
Progression Delaying Effect of Escitalopram in Alzheimer's DiseaseAlzheimer's DiseaseNCT00702780Seoul National University Hospital74
已完成
4 期
A Safety and Efficacy Study of Escitalopram on Acute Treatment of Severe DepressionMajor Depressive DisorderNCT01814085Xian-Janssen Pharmaceutical Ltd.225
已完成
4 期
Escitalopram for the Treatment of Depression in Alzheimer's DiseaseAlzheimer's DiseaseNCT01841125Konkuk University Medical Center84
已完成
不适用
Escitalopram in the Treatment of Postpartum DepressionPostpartum DepressionNCT01527474BC Women's Hospital & Health Centre20